← Eichor
Study identifier: NCT06842875 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Condition: Hypertension in Pregnancy · Postpartum Preeclampsia · Postpartum Complication  ·  Sponsor: Women and Infants Hospital of Rhode Island

PhaseNA
Planned participants1536
Who can joinFemale, 18 Years to 60 Years
Healthy volunteersNo

About this study

This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Nunez, Research Coordinator  ·  401-274-1122  ·  snunez@wihri.org

Always discuss trial participation with your own doctor first.

Locations (5)

Newport HospitalNewport, Rhode Island, United StatesNot Yet Recruiting
Women & Infants Hospital of Rhode IslandProvidence, Rhode Island, United StatesRecruiting
South County HospitalWakefield, Rhode Island, United StatesNot Yet Recruiting
Kent HospitalWarwick, Rhode Island, United StatesRecruiting
Landmark HospitalWoonsocket, Rhode Island, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06842875